Looking at the biotech space, Guy Adami of Drakon Capital likes Human Genome Sciences .
Joe Terranova of Vitrus Investment Partners recommends Precision Castparts .
On this dip, says Jon Najarian of optionMONSTER.com, Starbucks is a buy.
Click here to see other Final Trade posts.
Got something to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to firstname.lastname@example.org.